Related Experiment Video
Updated: Oct 25, 2025

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Antimicrobial Peptides with Antibacterial Activity against Vancomycin-Resistant Staphylococcus aureus Strains:
Isabella Hernández-Aristizábal1, Iván Darío Ocampo-Ibáñez1
1Research Group of Microbiology, Industry and Environment, Faculty of Basic Sciences, Universidad Santiago de Cali, Cali 760035, Colombia.
Abstract:
The emergence of bacteria resistant to conventional antibiotics is of great concern in modern medicine because it renders ineffectiveness of the current empirical antibiotic therapies. Infections caused by vancomycin-resistant Staphylococcus aureus (VRSA) and vancomycin-intermediate S. aureus (VISA) strains represent a serious threat to global health due to their considerable morbidity and mortality rates. Therefore, there is an urgent need of research and development of new antimicrobial alternatives against these bacteria. In this context, the use of antimicrobial peptides (AMPs) is considered a promising alternative therapeutic strategy to control resistant strains. Therefore, a wide number of natural, artificial, and synthetic AMPs have been evaluated against VRSA and VISA strains, with great potential for clinical application. In this regard, we aimed to present a comprehensive and systematic review of research findings on AMPs that have shown antibacterial activity against vancomycin-resistant and vancomycin-intermediate resistant strains and clinical isolates of S. aureus, discussing their classification and origin, physicochemical and structural characteristics, and possible action mechanisms. This is the first review that includes all peptides that have shown antibacterial activity against VRSA and VISA strains exclusively.
Insights
Antimicrobial peptides (AMPs) show promise as alternatives to antibiotics against resistant bacteria. This review details AMPs effective against vancomycin-resistant Staphylococcus aureus (VRSA) and vancomycin-intermediate S. aureus (VISA).
Area of Science:
- Microbiology
- Infectious Diseases
- Biochemistry
Background:
- Antibiotic resistance in Staphylococcus aureus, including vancomycin-resistant (VRSA) and vancomycin-intermediate (VISA) strains, poses a significant global health threat.
- The ineffectiveness of current antibiotics necessitates the development of novel therapeutic strategies to combat these resistant infections.
- Antimicrobial peptides (AMPs) are emerging as a promising alternative due to their broad-spectrum activity and unique mechanisms of action.
Purpose of the Study:
- To conduct a comprehensive systematic review of AMPs with demonstrated antibacterial activity against VRSA and VISA strains.
- To analyze the classification, origin, physicochemical properties, structural characteristics, and mechanisms of action of these AMPs.
- To consolidate existing research on AMPs as a potential therapeutic approach for challenging Staphylococcus aureus infections.
Main Methods:
- Systematic literature search for studies reporting AMPs effective against VRSA and VISA.
- Inclusion of research on natural, artificial, and synthetic AMPs.
- Analysis of data regarding peptide characteristics and antibacterial mechanisms.
Main Results:
- A wide array of AMPs, including natural, synthetic, and artificial variants, exhibit potent activity against VRSA and VISA.
- These AMPs possess diverse physicochemical and structural properties influencing their efficacy.
- Various mechanisms of action are proposed, often involving disruption of bacterial membranes.
Conclusions:
- AMPs represent a highly promising alternative therapeutic strategy for combating infections caused by vancomycin-resistant Staphylococcus aureus.
- Further research and development of AMPs could lead to novel treatments for multidrug-resistant bacterial infections.
- This review provides a foundational resource for understanding AMPs against VRSA and VISA, highlighting their clinical potential.
More Related Videos
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Antimicrobial Effectiveness
Development of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Bacterial Cell Wall

